Although MEL was reported to be cytostatic for cancer cells through ERK1/2 signaling [36,65,66], the stimulation of MEL on the MEK/ERK1/2 pathway was also shown to mediate protective signaling transduction [67] and cell proliferation [68]. Here, MAP2K7 is linked to cancer.